ViewRay Shares Rise

ViewRay Shares Rise

ViewRay shares rose 6% on Monday after the company said it presented “compelling early pancreatic cancer data” on its MRIdian radiation therapy system. The company said early results illustrated MRIdian’s ability to “deliver high doses with low toxicity, despite the proximity of the duodenum, through the use of daily plan adaptation and real-time tracking.” The company said that based on these data, it plans to support a multi-institutional single-arm prospective […]

Read More ˃